简介：Type2cytokinesareusuallypredominantintumorpatientsandassociatedwithtumorprogression.Toexplorewhetherreversingoftype2predominancecouldbeapromisingstrategyintumorimmunotherapy,PBMCsof35lungcancerpatientsand19healthysubjectswerepreparedandsubjectedtobeexaminedforcytokinesecretionandgeneexpression.Tetra-Methylpyrazine(TTMP),extractedfromatraditionalChinesemedicinalherbwhichhasbeenusedinclinictoreversetheTh2statusofcancerpatientsinChina,wasaddedtoPBMCculture.DeterminedbyRT-PCR,thepositivepercentagesofmRNAexpressionoftype1cytokines(8.6%forIFN-γand11.4%forIL-2)werelowerthanthoseoftype2cytokines(71.4%forIL-4,60%forIL-6and80%forIL-10)inpatients'PBMCs.Thepotentialofgeneexpressing(measuredasrelativeintensitytotheratioofβ-actin)inthepatientsfortype1cytokineswasalsoinalowlevel(0.111forIFN-γ,0.119forIL-2)incomparisonwitharelativehighlevelfortype2cytokines(0.319forIL-4,0.303forIL-6and0.377forIL-10).Meanwhile,bothpositivepercentageandrelativeintensityofgeneexpressionwerelowerforatype1cytokine-relatedtranscriptionfactorT-bet(31.4%and0.142,respectively)thanthosefortype2cytokine-relatedGATA3(85.7%and0.378,respectively).ThebloodserumlevelsofIFN-γandIL-2inthepatientswereslightlylowerbutnotsignificantlywhencomparedwithhealthycontrol.Incontrast,thelevelsIL-4andIL-6inpatientsweresignificantlyhigherthanthoseinhealthysubjectsbyELISAanalysis.TTMPcouldenhancesupernatantconcentrationandgeneexpressionlevelsofIFN-γ,IL-2andT-bet,butreducedthoseoftype2cytokines.Theseresultsdemonstratethatthelungcancerpatientshadapredominantexpressionoftype2cytokinesandTTMPcouldreversethetype2dominantstatus,whichmightofferanalternativetherapeuticregimeforlungcancerpatients.Cellular&MolecularImmunology.2004;1(1):63-70.
客服QQ：30444492琼网文【2021】1550-113号
增值电信业务经营许可证：琼B2-20210322
出版物经营许可证：新出发龙华出字第(2021)009号
广播电视节目制作经营许可证：(琼)字第00779号
版权所有 ©2002-2024 期刊网 琼ICP备2021005105号
